Company Charles River Laboratories International, Inc.

Equities

CRL

US1598641074

Biotechnology & Medical Research

Market Closed - Nyse 21:00:02 17/05/2024 BST 5-day change 1st Jan Change
221.6 USD -1.40% Intraday chart for Charles River Laboratories International, Inc. -2.85% -6.26%

Business Summary

Charles River Laboratories International, Inc. specializes in the development of products and services in the field of research and non-clinical drug development for pharmaceutical companies, government agencies and academic institutions. Net sales break down by activity as follows:

- discovery and safety assessment services (63.4%): discovery services for the identification, screening and selection of main compounds for the development of new drug candidates, and in vivo and in vitro testing, including pharmacokinetic, bioanalytical, metabolic, toxicological and pathological studies, for the safety assessment of pharmaceutical products, medical devices, animal health products, chemical and agrochemical products and biocides;

- development and sale of research models and related services (19.2%): mice, rats, immunodeficient models, rabbits, guinea pigs, hamsters, etc. The group also offers primary cells and specialized products (bioconservation products, freezing media for cell cultures, antigens, peptides, humanized mouse models, etc.) for the development and manufacture of new cell therapies ;

- development of solutions used in drug manufacturing processes (17.5%): products and services for microbiological testing, in vitro testing, endotoxin testing, microbial identification, development, manufacturing of avian vaccines, etc. The group also offers contract manufacturing services for cell and gene therapies.

Net sales break down by source of income between sales of services (83.3%) and sales of products (16.7%).

Net sales are distributed geographically as follows: the United States (56.8%), Europe (26%), Canada (11.8%), Asia/Pacific (4.9%) and other (0.4%).

Number of employees: 21,100

Sales per Business

USD in Million2022Weight2023Weight Delta
Discovery and Safety Assessment
63.3 %
2,447 61.6 % 2,616 63.3 % +6.88%
Research Models and Services
19.2 %
739 18.6 % 792 19.2 % +7.19%
Manufacturing Solutions
17.5 %
790 19.9 % 721 17.5 % -8.63%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
56.8 %
2,342 58.9 % 2,347 56.8 % +0.23%
Europe
26.1 %
1,032 26.0 % 1,077 26.1 % +4.34%
Canada
11.8 %
399 10.0 % 487 11.8 % +22.14%
Asia Pacific
4.9 %
193 4.8 % 201 4.9 % +4.15%
Other
0.4 %
10 0.3 % 17 0.4 % +69.19%

Managers

Managers TitleAgeSince
Chief Executive Officer 73 31/12/75
Director of Finance/CFO 51 24/04/22
Chief Operating Officer 54 31/03/89
Chief Tech/Sci/R&D Officer - 31/12/13
Chief Tech/Sci/R&D Officer - 31/01/21
Compliance Officer - 31/01/01
Compliance Officer - 31/12/04
Investor Relations Contact - 31/05/18
Comptroller/Controller/Auditor 47 25/04/17
Corporate Officer/Principal 64 31/12/11

Members of the board

Members of the board TitleAgeSince
Director/Board Member 76 31/12/02
Director/Board Member 68 30/09/19
Director/Board Member 61 24/01/11
Director/Board Member 67 28/10/08
Director/Board Member 73 23/01/11
Chief Executive Officer 73 31/12/75
Director/Board Member 68 04/07/17
Director/Board Member 71 01/12/13
Director/Board Member 65 27/02/20
Director/Board Member 58 15/10/20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 51,553,687 51,002,013 ( 98.93 %) 42,000 ( 0.0815 %) 98.93 %

Shareholders

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
11.78 %
6,046,467 11.78 % 1 377 M $
BlackRock Advisors LLC
8.572 %
4,401,758 8.572 % 1 003 M $
2,094,112 4.078 % 477 M $
Kayne Anderson Rudnick Investment Management LLC
3.657 %
1,877,630 3.657 % 428 M $
ClearBridge Investments LLC
2.947 %
1,513,138 2.947 % 345 M $
T. Rowe Price International Ltd.
2.575 %
1,322,454 2.575 % 301 M $
Geode Capital Management LLC
2.309 %
1,185,844 2.309 % 270 M $
Meritage Group LP
2.302 %
1,182,268 2.302 % 269 M $
Allspring Global Investments LLC
2.179 %
1,118,816 2.179 % 255 M $
Ariel Investments LLC
1.817 %
932,807 1.817 % 213 M $

Company contact information

Charles River Laboratories International, Inc.

251 Ballardvale Street

01887, Wilmington

+781 222 6000

http://www.criver.com
address Charles River Laboratories International, Inc.(CRL)

Group companies

NameCategory and Sector
Miscellaneous Commercial Services
Medical Specialties
Miscellaneous Commercial Services
Miscellaneous Commercial Services
Financial Conglomerates
Miscellaneous Commercial Services
Miscellaneous Commercial Services
Miscellaneous Commercial Services
Ballardvale CV
  1. Stock Market
  2. Equities
  3. CRL Stock
  4. Company Charles River Laboratories International, Inc.